꽃가루 알레르기 시장 규모는 향후 수년간 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 8.1%의 성장률(CAGR)을 기록하여 102억 6,000만 달러에 달할 것으로 예측됩니다. 예측 기간 중 예상되는 성장은 알레르기 질환의 유병률 증가, 오염 수준 증가, 기후 변화의 영향, 알레르기 치료에 대한 인식 증가, 치료 옵션의 가용성 확대, 의료 서비스 접근성 향상, 예방 조치 및 환경 위생에 대한 관심 증가 등 여러 요인에 기인합니다. 기인하고 있습니다. 이 기간의 주요 동향으로는 보다 효과적인 면역 요법 치료법 개발, 개인 맞춤형 알레르기 치료제의 채택, 꽃가루를 차단하는 비강 필터의 혁신, HEPA 필터가 장착된 공기청정기의 발전, 비강 스프레이 제형의 개선, 천연 유기농 알레르기 완화 제품의 인기 증가, 알레르기 항원 노출을 실시간으로 모니터링하는 웨어러블 기기을 실시간으로 모니터링하는 웨어러블 기기의 발전 등을 들 수 있습니다.
알레르기성 비염의 유병률 증가는 꽃가루 알레르겐 시장의 성장을 가속할 것으로 예측됩니다. 알레르기성 비염은 코에 염증을 일으켜 재채기, 코막힘, 눈 가려움증 등의 증상을 유발하는 질환으로 꽃가루나 먼지에 의해 유발되는 경우가 많습니다. 알레르기성 비염 증가는 환경오염, 기후 변화, 도시화, 라이프스타일의 변화 등 알레르기 항원 및 오염 물질에 노출될 기회가 증가하는 요인과 관련이 있습니다. 이 증상은 일반적으로 꽃가루 알레르기에 의해 발생하며, 꽃가루와의 접촉으로 인해 비강에 염증이 발생합니다. 예를 들어 2023년 10월, 미국에 본부를 둔 알레르기 임상 연구 전문 기관인 세계 알레르기 기구(World Allergy Organization)는 전 세계에서 4억 명 이상이 알레르기 비염을 앓고 있으며, 유병률은 성인의 경우 10%에서 30%, 소아의 경우 40% 이상의다고 보고했습니다. 그 결과, 알레르기 비염의 유병률 증가가 꽃가루 알레르겐 시장의 확대를 견인하고 있습니다.
꽃가루 알레르기 시장의 주요 기업은 알레르기의 진단, 치료, 관리를 위한 통합 솔루션을 제공하고 환자의 예후 개선과 편의성을 보장하는 종합적인 알레르기 치료 플랫폼 구축에 주력하고 있습니다. 꽃가루 알레르기 종합 치료 플랫폼은 꽃가루 알레르기 환자를 처음부터 끝까지 지원하기 위해 설계된 종합적인 시스템 및 서비스를 말합니다. 예를 들어 2023년 2월 인도 제약회사 넥타 생명과학(Nectar Life Science)는 종합 알레르기 치료 플랫폼인 넥타(Nectar)를 출시하고, 첫 번째 제품으로 개인 맞춤형 혀 밑 면역 치료제를 출시했습니다. 넥타의 알레르기용 방울은 CLIA 인증 가정용 알레르기 검사를 기반으로 알레르기의 근본 원인을 목표로 맞춤형으로 처방됩니다. 주사나 항히스타민제와 같은 기존 치료법을 대체할 수 있는 편리하고 효과적인 치료법입니다. 이 프로그램은 중등도에서 중증의 알레르기 환자들이 장기적인 내성을 형성하고 증상을 완화할 수 있도록 3개월에 한 번씩 배달과 지속적인 처방을 통해 치료 과정을 간소화합니다. 이 혁신적인 접근 방식은 개인화, 편의성, 입증된 효과를 결합하여 알레르기 치료의 혁신을 목표로 하고 있습니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 꽃가루 알레르기 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 용도 산업의 분석
- 세계의 꽃가루 알레르기 시장 : 성장률 분석
- 세계의 꽃가루 알레르기 시장 실적 : 규모와 성장, 2019-2024
- 세계의 꽃가루 알레르기 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 꽃가루 알레르기 TAM(Total Addressable Market)
제6장 시장 세분화
- 세계의 꽃가루 알레르기 시장 : 제품 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 기기
- 소모품
- 서비스
- 세계의 꽃가루 알레르기 시장 : 알레르겐 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 식품
- 흡입
- 약
- 기타 알레르겐 유형
- 세계의 꽃가루 알레르기 시장 : 치료제 클래스별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 항히스타민제
- 충혈 완화제
- 코르티코스테로이드
- 비만세포 안정제
- 류코트리엔 저해제
- 비강 항콜린제
- 면역 조절약
- 자기 주사용 에피네프린
- 면역치료
- 세계의 꽃가루 알레르기 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 진단 검사실
- 병원
- 세계의 꽃가루 알레르기 시장, 기기의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 알레르기 검사기기
- 진단 기기
- 감시 디바이스
- 세계의 꽃가루 알레르기 시장, 소모품의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 알레르기 검사 키트
- 화분 필터
- 진단 시약
- 치료제(항히스타민제)
- 세계의 꽃가루 알레르기 시장, 서비스의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 알레르기 검사 서비스
- 면역치료 서비스
- 상담·진단 서비스
제7장 지역별·국가별 분석
- 세계의 꽃가루 알레르기 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 꽃가루 알레르기 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 꽃가루 알레르기 시장 : 경쟁 구도
- 꽃가루 알레르기 시장 : 기업 개요
- Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- Bayer AG Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 대기업과 혁신적 기업
- Sanofi SA
- AstraZeneca Plc
- Novartis AG
- GlaxoSmithKline PLC
- Astellas Pharma Inc.
- Bausch Health Companies Inc.
- Sun Pharmaceutical Industries Ltd
- Genentech Inc.
- Omega Pharma
- ALK Abello
- Stallergenes Greer
- Aimmune Therapeutics
- Allergy Therapeutics
- McNeil Consumer Healthcare
- Meda Pharmaceuticals Inc
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 합병과 인수
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 꽃가루 알레르기 시장 2029 : 새로운 기회를 제공하는 국가
- 꽃가루 알레르기 시장 2029 : 새로운 기회를 제공하는 부문
- 꽃가루 알레르기 시장 2029 : 성장 전략
제36장 부록
KSA
Pollen allergy is an immune system response to pollen from trees, grasses, and weeds. It occurs when the immune system mistakenly identifies pollen as harmful, triggering the release of chemicals such as histamine. Pollen allergies are typically seasonal, with symptoms peaking in spring, summer, or fall, depending on the type of pollen an individual is allergic to.
The pollen allergy market includes key product categories such as instruments, consumables, and services. Instruments are medical devices used for diagnosing, monitoring, and treating pollen allergies. Examples include nasal irrigation devices, allergy testing equipment, and inhalers. Allergens are classified into food, inhaled, drug, and other types. Treatments for pollen allergies encompass antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergics, immunomodulators, auto-injectable epinephrine, and immunotherapy. These products are mainly used in diagnostic laboratories and hospitals.
The pollen allergy market research report is one of a series of new reports from The Business Research Company that provides pollen allergy market statistics, including the pollen allergy industry's global market size, regional shares, competitors with a pollen allergy market share, detailed pollen allergy market segments, market trends and opportunities, and any further data you may need to thrive in the pollen allergy industry. This pollen allergy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The pollen allergy market size has grown strongly in recent years. It will grow from $6.92 billion in 2024 to $7.51 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth observed in the historic period can be attributed to several factors, including increased awareness of allergic conditions, higher investments in healthcare infrastructure, the impact of climate change resulting in longer pollen seasons, and the rise in urbanization, which has led to greater exposure to allergens.
The pollen allergy market size is expected to see strong growth in the next few years. It will grow to $10.26 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth anticipated during the forecast period can be attributed to several factors, including the rising prevalence of allergic conditions, increasing pollution levels, the ongoing effects of climate change, greater awareness of allergy treatments, the expanding availability of treatment options, improved healthcare access, and a heightened focus on preventive measures and environmental health. Key trends during this period include the development of more effective immunotherapy treatments, the adoption of personalized allergy medications, innovations in pollen-blocking nasal filters, advancements in air purifiers equipped with HEPA filters, improvements in nasal spray formulations, the growing popularity of natural and organic allergy relief products, and the advancement of wearable devices that monitor allergen exposure in real-time.
The increasing prevalence of allergic rhinitis is expected to drive the growth of the pollen allergen market. Allergic rhinitis is a condition that causes inflammation in the nose, leading to symptoms such as sneezing, nasal congestion, and itchy eyes, often triggered by pollen or dust. The rise in allergic rhinitis is linked to factors such as environmental pollution, climate change, urbanization, and lifestyle changes, which increase exposure to allergens and pollutants. This condition is commonly caused by pollen allergies, where contact with pollen leads to inflammation in the nasal passages. For example, in October 2023, the World Allergy Organization, a US-based organization focused on clinical allergic studies, reported that allergic rhinitis affects more than 400 million people worldwide, with prevalence rates ranging from 10% to 30% in adults and surpassing 40% in children. As a result, the growing prevalence of allergic rhinitis is driving the expansion of the pollen allergen market.
Leading companies in the pollen allergy market are focusing on creating comprehensive allergy care platforms that offer integrated solutions for the diagnosis, treatment, and management of allergies, ensuring better patient outcomes and convenience. A comprehensive allergy care platform for pollen allergy is an all-encompassing system or service designed to support individuals with pollen allergies from start to finish. For example, in February 2023, Nectar Life Sciences, a pharmaceutical company based in India, launched Nectar, a comprehensive allergy care platform, and introduced personalized sublingual immunotherapy drops as its first product. These custom-formulated Nectar allergy drops are based on a CLIA-certified at-home allergy test and target the root cause of allergies. They provide a convenient and effective alternative to traditional treatments such as shots and antihistamines. The program simplifies the treatment process with home delivery and ongoing prescriptions every three months, helping patients with moderate to severe allergies build long-term tolerance and reduce symptoms. This innovative approach aims to transform allergy care by combining personalization, convenience, and proven effectiveness.
In September 2023, Stallergenes Greer International AG, a pharmaceutical company based in Switzerland, acquired the peanut allergy oral immunotherapy treatment Palforzia from Nestle S.A. for an undisclosed sum. This acquisition enhances Stallergenes' position as a leader in allergen immunotherapy by broadening its portfolio to include both respiratory and food allergy treatments. Nestle S.A., a Swiss food and beverage company, is actively involved in addressing a range of allergies, including food and environmental allergies such as those related to pollen.
Major players in the pollen allergy market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck KGaA, AbbVie Inc., Bayer AG, Sanofi SA, AstraZeneca Plc, Novartis AG, GlaxoSmithKline PLC, Astellas Pharma Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd, Genentech Inc., Omega Pharma, ALK Abello, Stallergenes Greer, Aimmune Therapeutics, Allergy Therapeutics, McNeil Consumer Healthcare, Meda Pharmaceuticals Inc, HAL Allergy Group, Allergopharma, Biomay AG, Leti Pharma, Epigenomics AG, Alerpharma S.A
North America was the largest region in the pollen allergy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pollen allergy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the pollen allergy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pollen allergy market consists of sales of nasal sprays, eye drops, allergy masks, air purifiers, and pollen blockers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pollen Allergy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on pollen allergy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for pollen allergy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pollen allergy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Product Type: Instruments; Consumables; Services
- 2) By Allergen Type: Food; Inhaled; Drug; Other Allergen Types
- 3) By Therapeutics Drug class: Antihistamines; Decongestants; Corticosteroids; Mast Cell Stabilizers; Leukotriene Inhibitors; Nasal Anticholinergics; Immunomodulators; Auto injectable Epinephrine; Immunotherapy
- 4) By End-User: Diagnostic Laboratories; Hospitals
- Subsegments:
- 1) By Instruments: Allergy Testing Equipment; Diagnostic Devices; Monitoring Devices
- 2) By Consumables: Allergy Test Kits; Pollen Filters; Diagnostic Reagents; Treatment Medications (Antihistamines)
- 3) By Services: Allergy Testing Services; Immunotherapy Services; Consultation And Diagnostic Services
- Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck KGaA; AbbVie Inc.; Bayer AG
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Pollen Allergy Market Characteristics
3. Pollen Allergy Market Trends And Strategies
4. Pollen Allergy Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Pollen Allergy Growth Analysis And Strategic Analysis Framework
- 5.1. Global Pollen Allergy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Pollen Allergy Market Growth Rate Analysis
- 5.4. Global Pollen Allergy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Pollen Allergy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Pollen Allergy Total Addressable Market (TAM)
6. Pollen Allergy Market Segmentation
- 6.1. Global Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Instruments
- Consumables
- Services
- 6.2. Global Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Food
- Inhaled
- Drug
- Other Allergen Types
- 6.3. Global Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antihistamines
- Decongestants
- Corticosteroids
- Mast Cell Stabilizers
- Leukotriene Inhibitors
- Nasal Anticholinergics
- Immunomodulators
- Auto Injectable Epinephrine
- Immunotherapy
- 6.4. Global Pollen Allergy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Diagnostic Laboratories
- Hospitals
- 6.5. Global Pollen Allergy Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Allergy Testing Equipment
- Diagnostic Devices
- Monitoring Devices
- 6.6. Global Pollen Allergy Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Allergy Test Kits
- Pollen Filters
- Diagnostic Reagents
- Treatment Medications (Antihistamines)
- 6.7. Global Pollen Allergy Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Allergy Testing Services
- Immunotherapy Services
- Consultation And Diagnostic Services
7. Pollen Allergy Market Regional And Country Analysis
- 7.1. Global Pollen Allergy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Pollen Allergy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Pollen Allergy Market
- 8.1. Asia-Pacific Pollen Allergy Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Pollen Allergy Market
- 9.1. China Pollen Allergy Market Overview
- 9.2. China Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Pollen Allergy Market
- 10.1. India Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Pollen Allergy Market
- 11.1. Japan Pollen Allergy Market Overview
- 11.2. Japan Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Pollen Allergy Market
- 12.1. Australia Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Pollen Allergy Market
- 13.1. Indonesia Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Pollen Allergy Market
- 14.1. South Korea Pollen Allergy Market Overview
- 14.2. South Korea Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Pollen Allergy Market
- 15.1. Western Europe Pollen Allergy Market Overview
- 15.2. Western Europe Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Pollen Allergy Market
- 16.1. UK Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Pollen Allergy Market
- 17.1. Germany Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Pollen Allergy Market
- 18.1. France Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Pollen Allergy Market
- 19.1. Italy Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Pollen Allergy Market
- 20.1. Spain Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Pollen Allergy Market
- 21.1. Eastern Europe Pollen Allergy Market Overview
- 21.2. Eastern Europe Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Pollen Allergy Market
- 22.1. Russia Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Pollen Allergy Market
- 23.1. North America Pollen Allergy Market Overview
- 23.2. North America Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Pollen Allergy Market
- 24.1. USA Pollen Allergy Market Overview
- 24.2. USA Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Pollen Allergy Market
- 25.1. Canada Pollen Allergy Market Overview
- 25.2. Canada Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Pollen Allergy Market
- 26.1. South America Pollen Allergy Market Overview
- 26.2. South America Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Pollen Allergy Market
- 27.1. Brazil Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Pollen Allergy Market
- 28.1. Middle East Pollen Allergy Market Overview
- 28.2. Middle East Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Pollen Allergy Market
- 29.1. Africa Pollen Allergy Market Overview
- 29.2. Africa Pollen Allergy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Pollen Allergy Market, Segmentation By Allergen Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Pollen Allergy Market, Segmentation By Therapeutics Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Pollen Allergy Market Competitive Landscape And Company Profiles
- 30.1. Pollen Allergy Market Competitive Landscape
- 30.2. Pollen Allergy Market Company Profiles
- 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
31. Pollen Allergy Market Other Major And Innovative Companies
- 31.1. Sanofi SA
- 31.2. AstraZeneca Plc
- 31.3. Novartis AG
- 31.4. GlaxoSmithKline PLC
- 31.5. Astellas Pharma Inc.
- 31.6. Bausch Health Companies Inc.
- 31.7. Sun Pharmaceutical Industries Ltd
- 31.8. Genentech Inc.
- 31.9. Omega Pharma
- 31.10. ALK Abello
- 31.11. Stallergenes Greer
- 31.12. Aimmune Therapeutics
- 31.13. Allergy Therapeutics
- 31.14. McNeil Consumer Healthcare
- 31.15. Meda Pharmaceuticals Inc
32. Global Pollen Allergy Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Pollen Allergy Market
34. Recent Developments In The Pollen Allergy Market
35. Pollen Allergy Market High Potential Countries, Segments and Strategies
- 35.1 Pollen Allergy Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Pollen Allergy Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Pollen Allergy Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
